COVID-19’s Limited Impact on Drug Shortages in Canada-Reference-Cited by-同舟云学术

COVID-19’s Limited Impact on Drug Shortages in Canada

Published:2020-10-01 Issue:S3 Volume:46 Page:S307-S312
ISSN:0317-0861
Container-title:Canadian Public Policy
language:en
Short-container-title:Canadian Public Policy

Author:

Gaudette Étienne¹

Affiliation:

1. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario

Abstract

Using data from the Drug Shortages Canada website, we ask whether the first months of the coronavirus disease 2019 (COVID-19) pandemic were associated with a significant increase in drug shortages in Canada. We find an increase of 147 shortages (32 percent) reported by manufacturers during March and April 2020 relative to the same months in previous years. The upsurge was concentrated during the two-week period from 25 March to 7 April 2020, after which report counts returned to usual levels. Excess reports cite both supply-side and demand-side causes for shortages. Increases were noted in therapeutic classes associated with COVID-19 care.

Publisher

University of Toronto Press Inc. (UTPress)

Subject

Public Administration,Sociology and Political Science

Link

https://utpjournals.press/doi/pdf/10.3138/cpp.2020-107

Reference19 articles.

1. Bidstats. 2019. “Essential Medicines Buffer Stock of Intravenous and Peritoneal Dialysis Fluids.” At http://bidstats.uk/tenders/2019/W33/709034340.

2. Canada. 2018. Towards Implementation of National Pharmacare Discussion Paper. At https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/implementation-national-pharmacare/discussion-paper.html.

3. Canada. 2020a. Exceptional Importation and Sale of Drugs in Relation to COVID-19: Tier 3 Drug Shortages. At https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html.

4. Canada. 2020b. Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19. At https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods.html.

5. Canadian Pharmacists Association. 2020. “Statement on 30-Day Supply of Prescription Medications.” At https://www.pharmacists.ca/news-events/news/statement-on-30-day-supply-of-prescription-medications/.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Health Commodities Supply Chain in the Era of COVID-19 Pandemic: Challenges, Impacts, and Prospects: A Systematic Review;Journal of Multidisciplinary Healthcare;2024-04

2. Queering Public Health: A Critical Examination of Healthcare Access and Gender Expression among Trans, Nonbinary, and Other Gender Nonconforming People during COVID-19;Health & Social Care in the Community;2023-03-04

3. The impact of the coronavirus pandemic on sedation in critical care: volatile anesthetics in the ICU;Current Opinion in Critical Care;2022-12-09

4. COVID-19 and the prevalence of drug shortages in Canada: a cross-sectional time-series analysis from April 2017 to April 2022;Canadian Medical Association Journal;2022-06-12